Details der Publikation

Medienart:	Klinische Studie

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	WHO International Clinical Trials Registry Platform - (2023) vom: 09. Jan. Zur Gesamtaufnahme - year:2023

Sprache:	Unbestimmt

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: advanced gastric cancer with lymph node metastases cannot be resected curatively, or poor prognosis. Recruitment Status: Not yet recruiting Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 26-03-2019, Last updated: 2023-01-13

ICTRP ID:	JPRN-jRCTs051180186 UMIN000028749

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	WHO004581326


LEADER	01000caa a22002652 4500
001	WHO004581326
003	DE-627
005	20230425173015.0
007	cr uuu---uuuuu
008	210507s2023 xx \|\|\|\|\|o 00\| \|\|und c
035			\|a (DE-627)WHO004581326
035			\|a (UBBS_Klinische_Studien_WHO)JPRN-jRCTs051180186
035			\|a (UBBS_Klinische_Studien_WHO)UMIN000028749
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a und
245	1	0	\|a OGSG 1701 \|b A phase II study of perioperative capecitabine plus Oxaliplatin(CapeOx) therapy for advanced gastric cancer with multiple lymph node metastases - OGSG 1701
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 26-03-2019, Last updated: 2023-01-13
650		4	\|a Medical Condition: advanced gastric cancer with lymph node metastases cannot be resected curatively, or poor prognosis.
650		4	\|a Study Type: Interventional
650		4	\|a Recruitment Status: Not yet recruiting
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2023) vom: 09. Jan.
773	1	8	\|g year:2023 \|g day:09 \|g month:01
856	4	0	\|u https://jrct.niph.go.jp/latest-detail/jRCTs051180186 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
912			\|a SSG-OLC-PHA
951			\|a AR
952			\|j 2023 \|b 09 \|c 01